Destination Wealth Management Eli Lilly & CO Transaction History

Destination Wealth Management

$3.19 Billion
Q3 2024

A detailed history of Destination Wealth Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Destination Wealth Management holds 27,326 shares of LLY stock, worth $21.7 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares

27,326

Previous 1,854 1373.89%

Holding current value

$21.7 Million

Previous $1.68 Million 1342.73%

% of portfolio

0.76%

Previous 0.06%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 25, 2024	BUY	$772.14 - $960.02 $19.7 Million - $24.5 Million	25,472 Added 1373.89%	27,326 $24.2 Million
Q2 2024 Jul 24, 2024	BUY	$724.87 - $909.04 $42,042 - $52,724	58 Added 3.23%	1,854 $1.68 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $257,014 - $343,849	-434 Reduced 19.46%	1,796 $1.4 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $205,874 - $242,698	392 Added 21.33%	2,230 $1.3 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $67,378 - $92,891	155 Added 9.21%	1,838 $987,000
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $21,745 - $29,076	62 Added 3.82%	1,683 $789,000
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $90,129 - $102,712	-304 Reduced 15.79%	1,621 $524,000
Q2 2022 Jul 29, 2022	BUY	$278.73 - $327.27 $83,897 - $98,508	301 Added 18.53%	1,925 $624,000
Q1 2022 May 12, 2022	SELL	$234.69 - $291.66 $81,437 - $101,206	-347 Reduced 17.61%	1,624 $465,000
Q4 2021 Feb 04, 2022	BUY	$224.85 - $279.04 $192,471 - $238,858	856 Added 76.77%	1,971 $544,000
Q3 2021 Oct 25, 2021	SELL	$221.6 - $272.71 $63,156 - $77,722	-285 Reduced 20.36%	1,115 $258,000
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $51,456 - $66,558	285 Added 25.56%	1,400 $321,000
Q1 2021 May 05, 2021	BUY	$164.32 - $212.72 $183,216 - $237,182	1,115 New	1,115 $208,000
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $804,877 - $968,662	-5,900 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$119.05 - $147.35 $39,524 - $48,920	-332 Reduced 5.33%	5,900 $818,000
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $16,018 - $17,424	-150 Reduced 2.35%	6,232 $697,000
Q2 2019 Jul 19, 2019	SELL	$110.79 - $129.32 $18,058 - $21,079	-163 Reduced 2.49%	6,382 $707,000
Q1 2019 May 01, 2019	SELL	$111.31 - $131.02 $51,981 - $61,186	-467 Reduced 6.66%	6,545 $849,000
Q4 2018 Feb 05, 2019	BUY	$105.9 - $118.64 $33,040 - $37,015	312 Added 4.66%	7,012 $811,000
Q3 2018 Nov 07, 2018	SELL	$85.86 - $107.31 $172,063 - $215,049	-2,004 Reduced 23.02%	6,700 $719,000
Q2 2018 Jul 31, 2018	BUY	$75.7 - $86.88 $651,095 - $747,254	8,601 Added 8350.49%	8,704 $743,000
Q1 2018 Apr 05, 2018	BUY	$74.21 - $87.6 $7,643 - $9,022	103 New	103 $5,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Destination Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Destination Wealth Management with notifications on news.

Account

Destination Wealth Management Eli Lilly & CO Transaction History